CLINICAL_TRIALS
research
· 2026-03-19
Clinical Trial Update: Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa [EARLY_Phase 1]
Summary
This is an early Phase 1 trial evaluating a self-assembled skin substitute for Epidermolysis Bullosa Dystrophica, with the study currently active but not recrui…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CHU de Quebec-Universite Laval | Conditions: Epidermolysis Bullosa Dystrophica | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING